Results of a meta-analysis concerning the impact of HT on low-grade systematic inflammation indicated that overt HT was associated with a significant increase in C-reactive protein (CRP) levels, but levothyroxine replacement therapy decreased CRP levels [11]. This evidence concerns the gene CRP and hematocrit.